Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

03.08.21	Amgen Reports Second Quarter 2021 Financial Results (PR Newswire)
30.07.21	Amgen Announces 2021 Third Quarter Dividend (PR Newswire)
30.07.21	Amgen Appoints S. Omar Ishrak To Board Of Directors (PR Newswire)
29.07.21	Amgen Announces Webcast Of 2021 Second Quarter Financial Results (PR Newswire)
28.07.21	Amgen To Acquire Teneobio For $900 Mln (RTTNews)
27.07.21	Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments (PR Newswire)
14.07.21	Amgen And The International Federation of Psoriasis Associations Launch UPLIFT Innovation Challenge (PR Newswire)
08.07.21	Amgen : FDA Grants Priority Review For Tezepelumab In Treatment Of Asthma (RTTNews)
08.07.21	Tezepelumab Granted Priority Review By U.S. FDA (PR Newswire)
23.06.21	Amgen: Aimovig Approved In Japan To Suppress Onset Of Migraine Attacks In Adults (RTTNews)
23.06.21	Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults (PR Newswire)
15.06.21	Acclaimed Makeup Artist Allan Avendaño Opens Up About Personal Skin Condition: Provides INSIDE LOOK At Life With Plaque Psoriasis (PR Newswire)
04.06.21	Amgen Says Follow-up Phase 2 FIGHT Trial Data Shows Improved OS - Quick Facts (RTTNews)
01.06.21	Amgen, Kyowa Kirin To Jointly Develop, Commercialize KHK4083 - Quick Facts (RTTNews)
17.05.21	Sandoz Says US Supreme Court Denies Its Petition To Review Biosimilar Erelzi Case (RTTNews)
13.05.21	Amgen Says, 'Tezepelumab Reduced Exacerbations Requiring Hospitalization By 85%' (RTTNews)
11.05.21	Amgen To Present Four Cardiovascular Research Abstracts (RTTNews)
05.05.21	Amgen: FDA To Review SNDA For Otezla - Quick Facts (RTTNews)
27.04.21	Amgen Inc. Q1 adjusted earnings of $3.70 per share (RTTNews)
19.04.21	Amgen's Investigational Bemarituzumab Receives Breakthrough Therapy Designation (RTTNews)
16.04.21	Eli Lilly Requests FDA Revoke EUA For Bamlanivimab 700 Mg Alone - Quick Facts (RTTNews)
04.03.21	Amgen To Acquire Five Prime Therapeutics - Quick Facts (RTTNews)
26.02.21	AZN And Amgen's Tezepelumab Reduces Exacerbations In Patients With Severe, Uncontrolled Asthma (RTTNews)
22.02.21	Amgen Submits SNDA For Otezla For Adults With Mild-To-Moderate Plaque Psoriasis (RTTNews)
10.02.21	Lilly's COVID-19 Antibody Combination Receives Emergency Use Authorization In U.S. (RTTNews)
02.02.21	Amgen Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
31.01.21	Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions (RTTNews)
11.01.21	Amgen, AstraZeneca, Bristol Myers Squibb To Evaluate GRAIL's Cancer Early Detection Test (RTTNews)
29.12.20	Biotech Stocks Facing FDA Decision In January 2021 (RTTNews)
22.12.20	Amgen Submits Sotorasib Marketing Authorization Application To EMA (RTTNews)
22.12.20	Amgen: SOURCE Phase 3 Trial For Tezepelumab Fails To Meet Primary Endpoint (RTTNews)
13.12.20	Week Ahead In Pharma: FDA Decision, Review Of COVID-19 Vaccine, Data Readouts (MRNA, BCRX, ARVN...) (RTTNews)
01.12.20	MRNA Faces AdCom On Dec.17, NVAX To Begin Phase 3 COVID Vaccine Trials In US, Mexico, AMGN On Watch (RTTNews)
30.11.20	Biotech Stocks Facing FDA Decision In December 2020 (RTTNews)
23.11.20	Amgen Terminates Collaboration With Cytokinetics On Omecamtiv Mecarbil And AMG 594 (RTTNews)
10.11.20	AstraZeneca, Amgen Report Positive Results From Tezepelumab Trial In Severe Asthma (RTTNews)
08.11.20	Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing (RTTNews)
29.10.20	European Patent Office Rules In Favor Of Sanofi, Regeneron On Praluent (RTTNews)
28.10.20	Amgen Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
08.10.20	Amgen: GALACTIC-HF Trial Meets Primary Composite Endpoint; Fails To Meet Secondary Endpoint (RTTNews)
17.09.20	Eli Lilly, Amgen Ink Antibody Manufacturing Deal To Boost Supply For COVID-19 Therapies (RTTNews)
02.09.20	Antibodies Against COVID Do Not Decline Within 4 Months Of Diagnosis: Study (RTTNews)
25.08.20	Exxon Mobil, Pfizer Exit Dow Jones Industrial Average (RTTNews)
21.08.20	Amgen : FDA Approves New KYPROLIS For Multiple Myeloma (RTTNews)
04.08.20	ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. (RTTNews)
03.08.20	AbbVie, Amgen, Takeda Pharma Enroll First Patients In I-SPY COVID Trial (RTTNews)
28.07.20	Amgen Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
13.07.20	Amgen To Additionally Invest $421 Mln In China's BeiGene (RTTNews)
11.05.20	AstraZeneca Completes Recovery Of Global Rights To Brazikumab From Allergan (RTTNews)
08.05.20	Amgen:FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Dow Jones aktuell: Dow Jones fällt zum Start des Freitagshandels zurück
20.12.24		NASDAQ-Handel NASDAQ 100 schwächelt zum Start des Freitagshandels
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag
20.12.24		Börse Frankfurt: DAX präsentiert sich nachmittags leichter
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer
20.12.24		Wechsel bei Sanofi: Ex-Morphosys-Chef Kress tritt in den Verwaltungsrat ein -Sanofi-Aktie tiefer

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Dow Jones aktuell: Dow Jones fällt zum Start des Freitagshandels zurück

20.12.24

NASDAQ-Handel NASDAQ 100 schwächelt zum Start des Freitagshandels

20.12.24

Börse Frankfurt: So steht der LUS-DAX am Nachmittag

20.12.24

Börse Frankfurt: DAX präsentiert sich nachmittags leichter